newsfilter
← Latest News
PR Newswire·

Research Indicates Sustained High Plasma Concentrations of Buprenorphine Reduce Fentanyl-Induced Respiratory Depression in Opioid-Tolerant Participants

RICHMOND, Va., Jan. 27, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of data from a clinical pharmacology study designed to assess the ability of buprenorphine to reduce respiratory depression and apnea associated with es